Phio Pharmaceuticals Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$3.62 | $0 | |||
| 05/09/2024 | Q1 2024 | -$0.47 | $0 | |||
| 04/01/2024 | Q4 2023 | -$0.51 | $30,000 | |||
| 11/09/2023 | Q3 2023 | -$1.14 | $0 | |||
| 08/10/2023 | Q2 2023 | -$1.47 | $0 | |||
| 05/11/2023 | Q1 2023 | -$3.15 | $0 | |||
| 03/22/2023 | Q4 2022 | -$2.28 | $0 | |||
| 11/10/2022 | Q3 2022 | -$3.15 | $0 | |||
| 08/11/2022 | Q2 2022 | -$2.23 | $0 | |||
| 05/12/2022 | Q1 2022 | -$2.34 | $0 | |||
| 03/22/2022 | Q4 2021 | -$3.06 | $0 | |||
| 11/10/2021 | Q3 2021 | -$3.32 | $0 | |||
| 08/12/2021 | Q2 2021 | -$2.38 | $0 | |||
| 05/13/2021 | Q1 2021 | -$3.83 | $0 | |||
| 03/25/2021 | Q4 2020 | -$5.11 | $0 | |||
| 11/10/2020 | Q3 2020 | -$4.79 | $0 | |||
| 08/12/2020 | Q2 2020 | -$0.64 | -$4.04 | -3.4 | $0 | |
| 05/12/2020 | Q1 2020 | -$15.91 | $0 | |||
| 03/26/2020 | Q4 2019 | -$56.32 | $0 | |||
| 11/12/2019 | Q3 2019 | -$4.40 | -$54.39 | -49.99 | $0 |
Phio Pharmaceuticals Corp. Earnings: Frequently Asked Questions
-
Did Phio Pharmaceuticals Corp. beat their earnings estimates last quarter?
In the previous quarter, Phio Pharmaceuticals Corp. (:PHIOW) reported $-0.34 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.64 by $0.3.
-
How can I listen to Phio Pharmaceuticals Corp.'s earnings conference call?
The conference call for Phio Pharmaceuticals Corp.'s latest earnings report can be listened to online.
-
How can I read Phio Pharmaceuticals Corp.'s conference call transcript?
The conference call transcript for Phio Pharmaceuticals Corp.'s latest earnings report can be read online.
-
How much profit does Phio Pharmaceuticals Corp. generate each year?
Phio Pharmaceuticals Corp. (:PHIOW) has a recorded net income of $0. Phio Pharmaceuticals Corp. has generated $-46.76 earnings per share over the last four quarters.
-
What is Phio Pharmaceuticals Corp.'s price-to-earnings ratio?
Phio Pharmaceuticals Corp. (:PHIOW) has a price-to-earnings ratio of -6.37 and price/earnings-to-growth ratio is 0.02.
